2009
Established
11,500
Attendees
1,700
Speakers
2,050
Companies
“What does precision medicine look like in the real world, what is the state of the art, what are the next key developments, how do we scale it, what do we need to plan for, and what are the hurdles and issues we may encounter?”
Ralph Snyderman, M.D., PMWC 2017 Duke Program Co-Chair“As a team we are bringing cross-functional stakeholders of this exciting field together to exchange ideas and the learnings gathered so far that can be translated into new winning strategies for the future of precision medicine as a cutting edge development in healthcare.”
Geoff Ginsburg, M.D., Ph.D., PMWC 2017 Duke Program Co-Chair
Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology
Session Chair: Fred Ashbury, Viviphi Ltd.

A Discussion on Increasing Patient Access To Investigational Drugs
Session Chair: Marty Tenenbaum, Cancer Commons

How Patients Can Advance Precision Medicine and Why You Should Care
Session Chair: Moira Quinn, Charlotte Center City Partners

Trends in Comprehensive Study and Biological Sample Management
Session Chair: Andrew Brooks, Bioprocessing Solutions Alliance

Call for Oncologists to Learn About Precision Medicine
Session Chair: Vincent Miller, Foundation Medicine

Infrastructure and Computational Tools in Support of Research and Genomic Medicine
Session Chair: Elaine R. Mardis, Nationwide Children’s Hospital

Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost
Session Chair: Stuart Goldberg, Cota Healthcare Inc.

Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role
Session Chair: Chris Cournoyer, N-of-One

Accelerating Clinical Trials Using Comprehensive Liquid Biopsy
Session Chair: Daniel Simon, Guardant Health

Why Subsets are the Practice
Session Chair: Scott Zeger, Johns Hopkins Bloomberg School of Public Health

Informed Health Decisions Through Creating a Learning Ecosystem
Session Chair: Kenneth J. Pienta, Johns Hopkins University

ME/CFS: The Mysterious Illness Science Has Yet to Unravel
Session Chair: Zaher Nahle, Solve ME/CFS Initiative

Status Quo of Genome Sequencing in Cancer & Beyond
Session Chair: Charles M. Perou, GeneCentric Diagnostics

Approaches towards Understanding and Enhancing Human Longevity
Session Chair: Brad Perkins, Human Longevity

Leaders in Academia and Industry to Foster Biotechnology
Session Chair: Ralph Snyderman, Duke University
Testimonials
“PMWC has proven, time and time again, that it attracts thought-leaders from all the relevant fields and catalyzes crucial collaboration through inspiring and practical program content. This is the Conference for entrepreneurs to meet payors, and for researchers to connect with service providers and for clinicians to hear from leading providers.”
Lee Hood, PhD, MD“PMWC provides a valuable insight for physicians and others who may be wondering how close we are getting to realizing the arrival of personalized medicine. The conferences are helpful in understanding where and how the envelope is being pushed.”
Peter Paul Yu, MD, FACP, FASCO“PMWC is a very well organized conference based in Silicon Valley that addresses all of the salient issues facing personalized medicine and offers emerging personalized medicine companies a chance to showcase their latest innovations, reminding us how exciting the field is.”
Ed Abrahams, PhD